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ABSTRACT
Objectives: The aim of this study was to develop a
critical appraisal (CA) tool that addressed study design
and reporting quality as well as the risk of bias in
cross-sectional studies (CSSs). In addition, the aim
was to produce a help document to guide the non-
expert user through the tool.
Design: An initial scoping review of the published
literature and key epidemiological texts was undertaken
prior to the formation of a Delphi panel to establish key
components for a CA tool for CSSs. A consensus of
80% was required from the Delphi panel for any
component to be included in the final tool.
Results: An initial list of 39 components was
identified through examination of existing resources.
An international Delphi panel of 18 medical and
veterinary experts was established. After 3 rounds of
the Delphi process, the Appraisal tool for Cross-
Sectional Studies (AXIS tool) was developed by
consensus and consisted of 20 components. A detailed
explanatory document was also developed with the
tool, giving expanded explanation of each question and
providing simple interpretations and examples of the
epidemiological concepts being examined in each
question to aid non-expert users.
Conclusions: CA of the literature is a vital step in
evidence synthesis and therefore evidence-based
decision-making in a number of different disciplines.
The AXIS tool is therefore unique and was developed
in a way that it can be used across disciplines to aid
the inclusion of CSSs in systematic reviews, guidelines
and clinical decision-making.
INTRODUCTION
Critical appraisal (CA) is a skill central to
undertaking evidence-based practice which is
concerned with integrating the best external
evidence with clinical care. This is because
when reading any type of evidence, being
critical of all aspects of the study design, exe-
cution and reporting is vital for assessing its
quality before being applied to practice.1–3
Systematic reviews have been used to develop
guidelines and to answer important ques-
tions for evidence-based practice3 4 and CA
to assess the quality of studies that have been
included is a crucial part of this process.5
Teaching CA has become an important part
of the curriculum in medical schools and
plays a central role in the interpretation and
dissemination of research for evidence-based
practice.6–9
Traditionally, evidence-based practice has
been about using systematic reviews of rando-
mised controlled trials (RCTs) to inform the
use of interventions.10 However, other types/
designs of research studies are becoming
increasingly important in evidence-based
practice, such as diagnostic testing, risk
factors for disease and prevalence studies,10
hence systematic reviews in this area have
become necessary. Cross-sectional studies
(CSSs) are one of those study designs that
are of increasing importance in evidence-
based medicine (EBM). A CSS has been
deﬁned as: ‘An observational study whose
outcome frequency measure is prevalence.
The basis of a cross sectional study design is
that a sample, or census, of subjects is
obtained from the target population and the
presence or the absence of the outcome is
ascertained at a certain point’.11 Various
reporting guidelines are available for the cre-
ation of scientiﬁc manuscripts involving
observational studies which provide guidance
for authors reporting their ﬁndings.
Strengths and limitations of this study
▪ The development of a novel critical appraisal tool
that can be used across disciplines.
▪ A multimodal evidence-based approach was
used to develop the tool.
▪ Expertise was harnessed from a number of dif-
ferent disciplines.
▪ The Delphi panel was based on convenience and
may not encompass all eventual users of the
tool.
▪ A numerical scale to reflect quality was not
included in the final tool, which may be per-
ceived as a limitation.
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In addition, well-developed appraisal tools have been
created for readers assessing the quality of cohort and
case–control studies;12 13 however, there is currently a
lack of an appraisal tool speciﬁcally aimed at CSSs. The
Cochrane collaboration has developed a risk of bias tool
for non-randomised studies (ROBINS-I);14 however, this
is a generic tool for case–control and cohort studies that
do not facilitate a detailed and speciﬁc enough appraisal
to be able to fully critique a CSS, In addition, it is only
intended for use to assess risk of bias when making jud-
gements about an intervention. Two systematic reviews
failed to identify a standalone appraisal tool speciﬁcally
aimed at CSSs.12 13 Katrak et al identiﬁed that CA tools
had been formulated speciﬁcally for individual research
questions but were not transferable to other CSSs. We
identiﬁed an appraisal tool, developed in Spanish, which
speciﬁcally examined CSSs.15 Berra et al essentially con-
verted each reporting item identiﬁed in the STROBE
(STrengthening the Reporting of OBservational studies
in Epidemiology) reporting guidelines and turned them
into questions for their appraisal tool. Fundamentally,
the tool developed by Berra et al15 only appraises the
quality of reporting of CSSs and does not address risk of
bias or other aspects of study quality.16 Good quality of
reporting of a study means that all aspects of the
methods and the results are presented well and in line
with international standards such as STROBE;17
however, this is only one aspect of appraisal as a well-
reported study does not necessarily mean that the study
is of high quality. Bias (‘a systematic error, or deviation
from the truth, in results or inferences’5) and study
design are other areas that need to be considered when
assessing the quality of included studies as these can be
inherent even in a well-reported study.
As the need for the inclusion of CSSs in evidence syn-
thesis grows, the importance of understanding the
quality of reporting and assessment of bias of CSSs
becomes increasingly important. Therefore, a robust CA
tool to address the quality of study design and reporting
to enable the risk of bias to be identiﬁed is needed.
Delphi methods and use of expert groups are increas-
ingly being implemented to develop tools for reporting
guidelines and appraisal tools.18 19
The aim of this study was to develop a CA tool that
was simple to use, that addressed study design quality
(design and reporting) and risk of bias in CSSs. A sec-
ondary aim was to produce a document to aid the use of
the CA tool where appropriate.
METHODS
Development of the initial draft CA tool
The authors completed a systematic search of the litera-
ture for CA tools of CSSs (see online supplementary
table S1). A number of publications were identiﬁed in
the review and a number of key epidemiological texts
were also identiﬁed to assist in the development of the
new tool.1 11 12 15 17 20–29 MJD and MLB used these
resources to subjectively identify areas that were to be
included in the CA tool. These items were discussed
with RSD and a ﬁrst draft of the tool (see online
supplementary table S2) and accompanying help text
was created using previously published CA tools for
observational and other types of study designs, and
other reference documents.1 11 12 15 17 20–29 The help
text was directed at general users and was developed in
order to make the tool easy to use and understandable.
The ﬁrst draft of the CA tool was piloted with collea-
gues within the Centre for Evidence-based Veterinary
Medicine (CEVM) and the population health and
welfare research group at the School of Veterinary
Medicine and Science (SVMS), The University of
Nottingham and the Centre for Veterinary
Epidemiology and Risk Analyses in University College
Dublin (UCD). Colleagues used the tool to assess differ-
ent research papers of varying quality that used CSS
design methodology during journal clubs and research
meetings and provided feedback on their experience.
The tool was used in the analysis of CSSs for a
published systematic review.30 The tool was also trialled
in a journal club and percentage agreement analysis was
carried out and used to develop the tool further. The
CA tool was also sent via email to nine individuals
experienced with systematic reviews in veterinary medi-
cine and/or study design for informal feedback.
Feedback from the different groups was assessed and
any changes to the CA tool were made accordingly. The
analysis identiﬁed components that were to be included
in a second draft of the CA tool of CSSs (see online
supplementary table S3) which was used in the ﬁrst
round of the Delphi process.
The Delphi panel
The purpose of the Delphi panel was to reach consensus
on what components should be present in the CA tool
and aid the development of the help text. Participants
for the Delphi panel were sought from the ﬁelds of
EBM, evidence-based veterinary medicine (EVM), epi-
demiology, nursing and public health and were required
to be involved in university education in order to qualify
for selection. Personal contacts of the authors and well-
known academics in the EBM/EVM ﬁelds were used as
the initial contacts and potential members of the panel.
Email was used to contact potential participants for
enrolment in the Delphi study. These potential partici-
pants were also asked to provide additional recommen-
dations for other potential participants. All potential
participants were contacted a second time if no response
was received from the ﬁrst email; if no response was
received after the second email, the potential participant
was not included any further in the study.
Participants were included if:
▸ they held a postgraduate qualiﬁcation (eg, PhD, MSc,
European College Diploma in Veterinary Public
Health);
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▸ they were recognised through publication and/or key
note presentations for their work in EBM and veterin-
ary medicine, epidemiology or public health;
▸ taught at university level; and
▸ had authored in systematic reviews (in medicine or
veterinary medicine), reporting guidelines or CA.
The Delphi process
Prior to conducting the Delphi process, it was agreed
that consensus for inclusion of each component in the
tool would be set at 80%.31 32 This meant that the
Delphi process would continue until at least 80% of
the panel agreed a component should be included in
the ﬁnal tool. Only if a component met the consensus
criteria would it be included in the ﬁnal tool, the steer-
ing committee did not change any component once it
reached consensus or add any component that did not
go through the Delphi panel. In each round, if a compo-
nent had 80% consensus, it remained in the tool. If con-
sensus was lower than 80% but >50%, the component
was considered for modiﬁcation or was integrated into
other components that were deemed to require reassess-
ment for the next round of the Delphi. If consensus was
≤50%, components were removed from the tool.
The second draft (developed in phase I described
above) of the CA tool (see online supplementary table
S3) was circulated in the ﬁrst round of the Delphi
process to the panel using an online questionnaire
(SurveyGizmo). Participants were asked: if each compo-
nent of the tool should be included or not; if any com-
ponent required alteration or clariﬁcation; or if a
further component should be added. Participants were
asked to add any additional comments they had regard-
ing each component. A hyperlink to the online ques-
tionnaire with the tool was distributed to the panel using
email. Participants were given 4 weeks to complete their
assessment of the tool using the questionnaire.
Participants were reminded about the work required
after 1 week, and again 3 days before the Delphi round
was due to close. If participants failed to respond to a
speciﬁc round, they were still included in the following
rounds of the Delphi process. The process was repeated,
with a new draft of the CA tool circulated each time
based on the ﬁndings and consensus of the previous
round, until 80% consensus on all components of the
tool was achieved.
On the third round of the Delphi process, a draft of
the help text for the tool was also included in the ques-
tionnaire and consensus was sought as to whether the
tool was suitable for the non-expert user, and partici-
pants were asked to comment on the text. The responses
were compiled and analysed at the end of round
3. Consensus was sought for the suitability of the help
text for the non-expert user and set at 80%. However, if
consensus was lower than 80% but >50%, the help text
was considered for modiﬁcation. If comments were
given on the help text, these comments were integrated
into the help text of the tool.
RESULTS
The initial review of existing tools and texts identiﬁed 34
components that were deemed relevant for CA of CSSs
and were included in the ﬁrst draft of the tool (see
online supplementary table S2). When piloted, there
was an overall per cent agreement of 88.9%; however,
32.9% of the questions were unanswered. Postfeedback
modiﬁcation after the pilot study identiﬁed 37 compo-
nents to be included in the second draft of the CA tool
(see online supplementary table S3).
Twenty-seven potential participants were contacted for
the Delphi study. Eighteen experts (67%) agreed to par-
ticipate in the Delphi panel. The most common reasons
for not partaking were not enough time (n=5); of these,
four were lecturers with research and clinical duties and
one was a lecturer with research duties. Two contacts felt
they were not suitably qualiﬁed for the Delphi panel
(n=2); one was retired and the other was a lecturer with
research and clinical duties. Two contacts did not
respond to the emails; these were both lecturers with
research duties. Of those that took part, 8 were involved
in clinical, teaching and research duties and 10 were
involved in research and teaching, 5 of the participants
were veterinary surgeons and 6 were medical clinicians.
It was an international panel, including 10 participants
from the UK, 3 from Australia, 2 from the USA, 2 from
Canada and 1 from Egypt. Participants were qualiﬁed a
mean of 17.6 years (SD: 7.9) and the panel was made up
of participants from varying disciplines (table 1).
During round 1 (undertaken in February 2013) of the
Delphi process, 20 components reached consensus, 13
components were assessed to require modiﬁcation and it
was deemed appropriate to remove 4 components from
the tool. General comments mostly related to the tool
having too many components.
The tool needs to be succinct and easy and quick to use
if possible—too many questions could have an impact.
List is too long at present and contains too many things
that are general to all scientiﬁc studies.
Comments voiced included the discussion as part of
the CA process being unnecessary and potentially
misleading:
The interpretation should, in my opinion, come from the
methods and the results and not from what the author
thinks it means.
Table 1 The number of participants from each discipline
enrolled in the Delphi panel for the development of the
AXIS tool
Discipline N
Epidemiology 4
Evidence-based medicine 9
Evidence-based veterinary medicine 2
Public health 3
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I don’t believe a Discussion section should be part of a
critical appraisal.
Therefore, in round 1, the tool was modiﬁed in an
attempt to reduce its size and to encompass all com-
ments. For round 2 (undertaken in May 2013), 11 com-
ponents remained the same and did not require testing
for consensus as this was established in round 1; 9 com-
ponents that had previously reached consensus were
incorporated with the 13 components that required
modiﬁcation to create 10 new components (see online
supplementary table S4).
In round 2, consensus was reached on a further two
components, six components were assessed to require
modiﬁcation and it was deemed appropriate to remove
two components from the tool. Comments from the panel
regarding the components of the tool that related to the
discussion suggested further reduction in these compo-
nents due to their limited use as part of the CA process.
The discussion could legitimately be highly speculative
and not justiﬁed by the results provided that the authors
don’t present this as conclusions.
With the reduction in the number of questions and
modiﬁcation of the wording, comments in round 2
reﬂected the positive nature to the usability of the tool.
I like the fact that it is quite simple—not too overloaded
with methodological questions.
After round 2, the tool was further reduced in size
and modiﬁed to create a fourth draft of the tool with 20
components incorporating 13 components with full con-
sensus and 7 modiﬁed components for circulation in
round 3 of the Delphi process.
Following round 3 (undertaken in July 2013) of the
Delphi process, there was consensus (81%) that all com-
ponents of the tool were appropriate for use by non-
expert users, so no further rounds were necessary. The
ﬁnal CA tool for CSSs (AXIS tool) consisting of 20 com-
ponents is shown in table 2. The comments from the
panel regarding the help text were addressed and minor
modiﬁcations to the text were made (see online
supplementary material 4). Seven (1, 4, 10, 11, 12, 16
and 18) of the ﬁnal questions related to quality of
Table 2 The final AXIS tool following consensus on all components by the Delphi panel
Yes No
Do not know/
comment
Introduction
1 Were the aims/objectives of the study clear?
Methods
2 Was the study design appropriate for the stated aim(s)?
3 Was the sample size justified?
4 Was the target/reference population clearly defined? (Is it clear who the research was
about?)
5 Was the sample frame taken from an appropriate population base so that it closely
represented the target/reference population under investigation?
6 Was the selection process likely to select subjects/participants that were representative
of the target/reference population under investigation?
7 Were measures undertaken to address and categorise non-responders?
8 Were the risk factor and outcome variables measured appropriate to the aims of the
study?
9 Were the risk factor and outcome variables measured correctly using instruments/
measurements that had been trialled, piloted or published previously?
10 Is it clear what was used to determined statistical significance and/or precision
estimates? (eg, p values, CIs)
11 Were the methods (including statistical methods) sufficiently described to enable them
to be repeated?
Results
12 Were the basic data adequately described?
13 Does the response rate raise concerns about non-response bias?
14 If appropriate, was information about non-responders described?
15 Were the results internally consistent?
16 Were the results for the analyses described in the methods, presented?
Discussion
17 Were the authors’ discussions and conclusions justified by the results?
18 Were the limitations of the study discussed?
Other
19 Were there any funding sources or conflicts of interest that may affect the authors’
interpretation of the results?
20 Was ethical approval or consent of participants attained?
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reporting, seven (2, 3, 5, 8, 17, 19 and 20) of the ques-
tions related to study design quality and six related to
the possible introduction of biases in the study (6, 7, 9,
13, 14 and 15).
DISCUSSION
The AXIS tool
A CA tool to assess the quality and risk of bias in CSSs
(AXIS), along with supporting help text, was successfully
developed by an expert panel using Delphi method-
ology. This is the ﬁrst CA tool made available for
assessing this type of evidence that can be incorporated
in systematic reviews, guidelines and clinical
decision-making.
Key Delphi findings
One of the key items raised in comments from the
experts was assessing quality of design versus quality of
reporting. It is important to note that a well-reported
study may be of poor quality and conversely a poorly
reported study could be a well-conducted study.33 34 It is
also apparent that if a study is poorly reported, it can be
difﬁcult to assess the quality of the study. Some informa-
tion may be lacking due to poor reporting in studies,
making it difﬁcult to assess the risk of biases and the
quality of the study design. High quality and complete
reporting of studies is a prerequisite for judging
quality.17 18 35 For this reason, the AXIS tool incorpo-
rates some quality of reporting as well as quality of
design and risk of biases to overcome these problems.
Using the tool
The tool was also reduced in size on each round of the
Delphi process as commentators raised concerns around
developing a tool with too many questions. The com-
ments suggested that a long questionnaire would lead to
the tool being cumbersome and difﬁcult to use, and for
this reason, efforts were made to develop a much more
concise tool.
The AXIS tool focuses mainly on the presented
methods and results. It was the view of the Delphi group
that the assessment as to whether the published ﬁndings
of a study are credible and reliable should relate to the
aims, methods and analysis of what is reported and not
on the interpretation (eg, discussion and conclusion) of
the study. This view is also seen in other appraisal tools,
is shared by other researchers and can be seen by the
absence of questions relating to the discussion sections
in CA tools for other types of studies.12 16 20 28 36
As with all CA tools, it is only possible for the reader
to be able to critique what is reported. If an important
aspect of a study is not in the manuscript, it is unclear
to the reader whether it was performed, and not
reported, or not performed at all. It is therefore the
responsibility of the appraiser of the study to recognise
omissions in reporting and consider how this affects the
reliability of the results.
A comprehensive explanatory text is often used in
appraisal tools for different types of study designs as it
aids the reviewer when interpreting and analysing the
outputs from the appraisal.12 17–20 This approach was
also used in the development of the AXIS tool where a
reviewer can link each question to explanatory text to
aid in answering and interpreting the questions.
Study strengths and limitations
The tool was developed through a rigorous process
incorporating comprehensive review, testing and consult-
ation via a Delphi panel. Using a similar process to
other appraisal tools,37 we reviewed the relevant litera-
ture to develop a concise background on CA of CSSs
and to ensure no other relevant tools existed. While
numerous tools exist for CA, we found a lack of tools for
general use in CSSs and this was consistent with what
others have found previously.12 13 In order to ensure
quality and completeness of the tool, we utilised recog-
nised reporting guidelines, other appraisal tools and epi-
demiology design text in the development of the initial
tool which is similar to the development of appraisal
tools of other types of studies.12
The use of a multidisciplinary panel with experience
in epidemiology and EBM limits the effect of using a
non-representative sample, and the use of the Delphi
tool is well recognised for developing consensus in
healthcare science.38 The selection of a Delphi group is
very important as it effects the results of the process.31
As CSSs are used extensively in human and veterinary
research, it was appropriate to use expertise from both
of these ﬁelds. To ensure that the tool was developed to
a high standard, a high level of consensus was required
in order for the questions to be retained.31 32 39 There
was a high level of consensus between veterinary and
medical groups in this study, which adds to the rigour of
the tool but also demonstrates how both healthcare
areas can cooperate effectively to produce excellent
outcomes.
The Delphi study was conducted using a carefully
selected sample of experts and as such may not be rep-
resentative of all possible users of the tool. However, the
purpose of a Delphi study is to purposely hand pick
participants that have prior expertise in the area of inter-
est.40 The Delphi members came from a multidisciplin-
ary network of professionals from medicine, nursing and
veterinary medicine with experience in epidemiology
and EBM/EVM and exposure to teaching and areas of
EBM that were not just focused on systematic reviews of
RCTs. The panel was restricted to those that were literate
in the English language and may therefore not be repre-
sentative of all nationalities. The interests and experi-
ences of the panel will clearly have had an effect on the
results of this study as this is common to all Delphi
studies.31 41 The majority of Delphi studies are con-
ducted using between 15 and 20 participants,31 so a
panel of 18 is consistent with other published Delphi
panels. We aimed to recruit a minimum of 15
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participants and as it was anticipated that not all partici-
pants contacted would be able to take part, more partici-
pants were contacted.
As the tool does not provide a numerical scale for
assessing the quality of the study, a degree of subjective
assessment is required. This has implications for inter-
pretation after using the tool as there will be differences
in individuals’ judgements. However, it has been
debated that quality numerical scales can be problematic
as the outputs from assessment checklists are not linear
and as such are difﬁcult to sum up or weight making
them unpredictable at assessing study quality.39 42 43 The
AXIS tool has the beneﬁt of providing the user the
opportunity to assess each individual aspect of study
design to give an overall assessment of the quality of the
study. By providing this subjectivity, AXIS gives the user
more ﬂexibility in incorporating quality of reporting and
risk of bias when making judgements on the quality of a
paper. This tool therefore provides an advantage over,
Berra et al15 which only allows the user to assess quality
of reporting and tools such as the Cochrane risk of bias
tool5 which do not address poor reporting. Further
studies would be needed to assess how practical this tool
is when used by clinicians and if the CA of studies using
AXIS is repeatable.
CONCLUSION
In conclusion, a unique tool (AXIS) for the CA of CSSs
was developed that can be used across disciplines, for
example, health research groups and clinicians conduct-
ing systematic reviews, developing guidelines, undertak-
ing journal clubs and private personal study. The
components of the AXIS tool are based on a combin-
ation of evidence, epidemiological processes, experience
of the researchers and Delphi participants. As with
other evidence-based initiatives, the AXIS tool is
intended to be an organic item that can change and be
improved where required, with the validity of the tool to
be measured and continuously assessed. We would invite
any users of the tool to provide feedback, so that the
tool can be further developed if needed and can incorp-
orate user experience to provide better usability.
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